Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sangamo Therapeutics's price to sales ratio was 0.9× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.4× to 25.6×, with a median of 3.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.9× | −2.2 |
| 2025 | Dec 31, 2025 | 3.2× | −0.6 |
| 2024 | Dec 31, 2024 | 3.8× | +3.3 |
| 2023 | Dec 29, 2023 | 0.5× | −3.7 |
| 2022 | Dec 30, 2022 | 4.2× | −5.7 |
| 2021 | Dec 31, 2021 | 9.9× | −3.7 |
| 2020 | Dec 31, 2020 | 13.6× | +1.3 |
| 2019 | Dec 31, 2019 | 12.2× | −4.3 |
| 2018 | Dec 31, 2018 | 16.5× | −26.0 |
| 2017 | Dec 29, 2017 | 42.6× | +31.6 |
| 2016 | Dec 30, 2016 | 11.0× | −3.1 |
| 2015 | Dec 31, 2015 | 14.1× | −13.4 |
| 2014 | Dec 31, 2014 | 27.5× | −5.1 |
| 2013 | Dec 31, 2013 | 32.6× | +14.4 |
| 2012 | Dec 31, 2012 | 18.2× | +3.7 |
| 2011 | Dec 30, 2011 | 14.5× | – |
See a number that looks wrong?